# Cybersecurity Artificial Intelligence Framework – USA Healthcare AI Governance and Assurance
Version 0.1 (Draft)  
Author: Antonio José Socorro Marín  
Creator of CAI-EXPERT-LAB (Cybersecurity Artificial Intelligence Framework)  
Copyright © 2025 Antonio José Socorro Marín.  
All rights reserved.  
Use, distribution, modification, and commercial exploitation are governed by the legal documents contained in the /legal directory of this repository.  

**NOTE**  
The normative language of CAI-EXPERT-LAB documentation is English.  
This document defines Healthcare sector–specific AI governance and assurance constraints under the CAI USA framework. It does not assert compliance, certification, accreditation, or regulatory approval.  

## Purpose

The purpose of this document is to define mandatory governance, assurance, and limitation principles for the use of artificial intelligence within Healthcare environments under CAI USA. This document establishes controls to ensure that AI-assisted capabilities support cybersecurity analysis and decision-making while preserving patient safety, clinical authority, data integrity, accountability, and trust. It explicitly prevents AI autonomy, uncontrolled learning, and contamination of clinical or governance decision processes.

## Scope

This document applies exclusively to the Healthcare sector as defined in CAI-USA-Healthcare-Sector-Definition. It refines CAI USA AI governance expectations for healthcare environments without redefining CAI CORE semantics, CAI Engine execution authority, or USA baseline governance. It records governance and assurance constraints only and introduces no regulatory interpretations or compliance claims.

## AI Governance Principles for Healthcare

AI use in Healthcare must be conservative, transparent, and subordinate to human clinical and operational authority. AI systems may assist with analysis, correlation, prioritization, and recommendation generation. AI systems are explicitly prohibited from independently authorizing, executing, or modifying actions that could affect patient safety, clinical workflows, medical device behavior, access to patient data, or continuity of care.

## Non-Autonomy and Clinical Authority

Human authority is mandatory for all actions with potential patient or clinical impact. AI outputs are advisory only and must be reviewed, validated, and approved by authorized human operators. No AI system may independently trigger isolation, eviction, shutdown, configuration changes, privilege modifications, or restoration actions in Healthcare environments. Clinical override authority is absolute and non-delegable.

## Model Risk Management

All AI models used within Healthcare environments must undergo explicit model risk assessment prior to operational use. Model purpose, scope, assumptions, limitations, failure modes, and misuse risks must be documented. Models must be evaluated for false confidence risk, bias amplification, silent failure modes, and sensitivity to incomplete or manipulated data. Model updates are subject to controlled change management and approval.

## Explainability and Transparency

AI-assisted outputs must be explainable to clinicians, biomedical engineers, cybersecurity personnel, and auditors. Outputs must include rationale, confidence indicators, and contextual factors sufficient to support informed human judgment. Black-box decisioning without interpretable context is prohibited for healthcare cybersecurity use cases.

## Data Governance and Integrity

Training, validation, and inference data must be protected for integrity, provenance, and traceability. Data sources must be documented and monitored for poisoning, drift, corruption, or unauthorized modification. AI systems must not consume unvalidated, untrusted, or ambiguous data sources. Degradation of data quality is treated as a patient safety and governance risk.

## Drift Detection and Stability

AI systems must include mechanisms to detect data drift, model drift, and performance degradation. Drift indicators must be observable, auditable, and actionable. Automated retraining, self-modification, or adaptive behavior without explicit approval is prohibited. When drift is detected, models may be suspended or rolled back pending review.

## Inference Integrity and Output Controls

AI inference pipelines must be protected against manipulation, replay, spoofing, or tampering. Outputs must be integrity-protected and traceable to input data and model versions. Thresholds must be conservative and appropriate for high-consequence clinical environments. Confidence scoring does not replace human clinical judgment.

## Contamination Prevention

AI systems must not introduce contamination into authoritative clinical records, evidence repositories, configuration baselines, or governance artifacts. AI-generated content must be clearly labeled, segregated, and traceable. AI is prohibited from modifying clinical documentation, governance records, or traceability artifacts.

## Learning Constraints

Online, unsupervised, or autonomous learning is prohibited in Healthcare environments. Learning activities must occur offline, be reviewed, validated, and approved prior to deployment. Feedback loops that could reinforce incorrect assumptions, unsafe behaviors, or adversarial manipulation are explicitly disallowed.

## Integration with the CAI Lifecycle

MODEL may use AI to assist asset classification, dependency analysis, and risk prioritization under supervision.  
HARDEN may use AI to assist exposure identification and configuration analysis without automated remediation.  
DETECT may use AI for anomaly detection and correlation with conservative thresholds.  
ISOLATE, EVICT, and RESTORE may use AI for recommendation support only and require explicit human approval and safety gating prior to execution.

## Evidence and Accountability

All AI-assisted decisions must generate auditable evidence, including model identity, version, input references, confidence indicators, decision rationale, and human approval. Evidence must support investigation, legal review, and governance oversight. AI systems are subject to the CAI Dual Audit Pipeline.

## Relationship to CAI CORE

This document inherits CAI CORE integrity, self-defense governance, AI governance principles, contamination prevention rules, and evolution controls. It remains consistent with CAI-Core-Integrity-and-Self-Defense-Governance and CAI-Core-Dual-Audit-Pipeline.

## Relationship to CAI USA Baseline

This document refines CAI-USA-AI-Governance-and-Assurance and aligns with CAI-USA-AI-RMF-Map for Healthcare sector use. It operates alongside CAI-USA-ICS-OT-Safety-Gating, CAI-USA-CCES, and CAI-USA-Telemetry-and-Data-Model without altering baseline semantics.

## Explicit Non-Claims

This document does not assert compliance with HIPAA, HHS, FDA, DOJ, DHS, CISA, NIST, or any other authority. It does not certify AI systems, authorize operational changes, or replace regulatory, clinical, or safety processes.

Status  
Draft – USA Healthcare AI governance and assurance established.
This document defines the authoritative governance and assurance constraints for AI-assisted cybersecurity capabilities within Healthcare sector environments under CAI USA.

## End of Document